Pharmatory
Contract development and cGMP manufacturing of small-molecule APIs for human and veterinary pharma companies
Highlights
- New on EvolcAdded 2026-11-01
About Pharmatory
Pharmatory Oy is a private contract development and manufacturing company that provides small molecule synthesis, process R&D and cGMP production of active pharmaceutical ingredients (APIs). Its services include route scouting, API process development and scale-up, contract manufacturing of key intermediates and APIs, analytical services and generic API production.
Its customers are human and veterinary pharmaceutical companies, including companies running new chemical entity (NCE) development projects and companies with commercial products. Many projects come from repeat customers. Veterinary drugs are part of its GMP manufacturing, and it supplies regulatory documentation for them.
The company was founded in 2000 and is headquartered in Oulu, Finland, where its manufacturing facility is located. The facility is inspected by the European Medicines Agency (EMA/FIMEA) and by customers. In February 2026 MB Funds invested in the company, and the company has announced an expansion of its HPAPI facility in Oulu.
Product: Small molecule synthesis, API process development and scale-up, cGMP contract manufacturing, analytical services and generic APIs.
Jobs at Pharmatory
More biotech & pharma companies
Polku Therapeutics
Develops small-molecule therapies for neurodegenerative diseases by targeting tau aggregation and neuroinflammationYoung companyNew on EvolcPrecisionPhage
Phage genome bioinformatics software, lab services and a phage library for AMR and phage therapy researchYoung companyNew on EvolcPrimoceler
Hermetic glass packaging and laser bonding for active implantable device electronics, from prototype to series productionNew on EvolcProbiont
Develops organ-on-a-chip solutions to test cancer immunotherapy efficacy for personalized treatment assessmentNew on EvolcPuro Analytics
EDNA biodiversity monitoring for organisations: species detection, fish and forest surveys, lab analysis and reportsYoung companyNew on EvolcRappta Therapeutics
Develops first-in-class anti-cancer molecular glues that reactivate the tumor suppressor PP2A, for oncology drug developmentNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
E-commerce
- WooCommerceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- CookiebotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.